rss
Br J Ophthalmol 87:834-838 doi:10.1136/bjo.87.7.834
  • Clinical science
    • Scientific reports

Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases

Table 4

Demographic, risk factors, clinical, and microbiological characteristics of 15 cases of bacterial keratitis with “very poor outcome”

Sex Age Local risk factor Previous topical treatment Surface of infiltrate (mm2) Depth of stromal extension AC inflammation (Tyndall effect) Bacteria identified Duration of hospitalisation Outcome
CL = contact lenses wear, AC = anterior chamber, PBK = pseudophakic bullous keratopathy, BCVA = best corrected visual acuity, CF = counting fingers.
F 27 CL Oxybuprocaïne, fusidic acid 64 >2/3 Hypopyon 1 mm Pseudomonas aeruginosa 10 Central corneal scarring, BCVA 20/200
F 89 Exposure keratopathy None 16 >2/3 Hypopyon 1 mm Pseudomonas aeruginosa 12 Permanent tarsorrhaphy
M 25 CL None 16 >2/3 + Pseudomonas aeruginosa 11 Corneal scarring, BCVA 20/200
M 35 Exposure keratopathy Tobramycin 9 >2/3 + Streptococcus spp 8 Permanent tarsorrhaphy
M 71 Removal of corneal suture None 100 >2/3 Phtysis bulbi Streptococcus sanguis 20 Evisceration
F 7 Corneal trauma None 16 perforation +++ Streptococcus pneumoniae 13 Cyanoacrylate glue
M 36 PBK Rifamycin, chloramphenicol 4 1/3 + Streptococcus vestibularis 11 PK
M 50 Chronic ulcer of unknown aetiology Dexamethasone, neomycin 6 perforation +++ None 4 Conjunctival flap
M 86 PBK None 9 >2/3 Phtysis bulbi Staphylococcus aureus 7 Evisceration
F 83 Removal of corneal suture None 6 >2/3 Hypopyon 3 mm Staphylococcus aureus 15 Corneal scarring, BCVA 20/200
F 50 Blepharoplasty Oxybuprocaïne, norfloxacine 9 >2/3 ++ None 14 Corneal scarring, BCVA CF
F 27 Exposure keratopathy Norfloxacine, rifamycin 4 1/3–2/3 + None 3 Permanent tarsorrhaphy
F 45 Exposure keratopathy None 3 1/3–2/3 + Staphylococcus epidermidis 10 Permanent tarsorrhaphy
M 49 Chronic ulcer of unknown aetiology Tobramycin 24 >2/3 ++ Staphylococcus epidermidis 60 Conjunctival flap
M 69 Chronic ulcer of unknown aetiology None 9 >2/3 + None 19 PK

This Article

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.